MannKind Corporation is a biopharmaceutical company based in Westlake Village, California. The company is focused on the development of inhaled therapeutic products for patients with diabetes and pulmonary arterial hypertension. MannKind's lead product, Afrezza, is an inhaled insulin used to treat diabetes. The company was founded in 1991 and went public in 2004.